Target intelligence / Profile preview

Peripheral sensory pathways

Molecular classification
Other
01

Overview

Peripheral sensory pathways encompass the complex network of neurons and specialized receptors that transmit sensory information from the body's periphery to the central nervous system (StatPearls, 2023). This system includes primary afferent neurons, such as A-beta, A-delta, and C fibers, which are responsible for transducing mechanical, thermal, and chemical stimuli into electrical impulses (Nature Reviews Neuroscience, 2013). These pathways are essential for the perception of touch, temperature, and pain, serving as a critical interface between the organism and its environment. In pathological conditions like peripheral neuropathy or chronic inflammation, these pathways can become hypersensitized, leading to debilitating chronic pain syndromes (NIH, 2024). While not a single molecular target, the peripheral sensory pathway contains numerous specific proteins, such as Nav1.7 and TRPV1, that are targeted by drugs to provide localized analgesia (PubMed, 2021). Pharmacological interventions aim to dampen the excitability of these neurons to treat conditions like post-herpetic neuralgia and diabetic neuropathy. However, a significant challenge in targeting these pathways is achieving selectivity to avoid the loss of essential protective sensations or motor function.

Other names
Somatosensory systemPeripheral afferent pathwaysSensory nervous systemPeripheral sensory nervous system
02

Mechanism of action

Modulation of signal transmission through the inhibition of voltage-gated sodium channels (Nav), modulation of voltage-gated calcium channels (Cav2.2), or desensitization of transient receptor potential (TRP) channels located on primary afferent neurons (Nature Reviews Neuroscience, 2013; StatPearls, 2023).

03

Biological functions

Sensory transductionNociceptionProprioceptionThermoceptionMechanoreceptionSignal transmission
04

Disease associations

Neuropathic painChronic painPeripheral neuropathyInflammationAllodyniaHyperalgesia
05

Safety considerations

Loss of protective sensationParesthesiaNumbnessPotential for off-target motor weaknessDizzinessLocal tissue irritation (for topical agents)
06

Interacting drugs

Lidocaine

5 more in the full profile.

07

Biomarkers

Nerve conduction velocity (NCV)Intraepidermal nerve fiber density (IENFD)Quantitative sensory testing (QST)Skin biopsy

Beyond the preview

Go deeper on Peripheral sensory pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peripheral sensory pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call